4//SEC Filing
Gaston-Dreyfus Remi 4
Accession 0001104659-21-149127
CIK 0001508381other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:32 PM ET
Size
11.9 KB
Accession
0001104659-21-149127
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-07-15−115,759→ 0 totalExercise: $3.60From: 2020-07-26Exp: 2026-07-26→ Common Stock, par value $0.001 per share (115,759 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-07-15−5,000→ 0 totalExercise: $3.16Exp: 2026-05-31→ Common Stock, par value $0.001 per share (5,000 underlying) - Exercise/Conversion
Common Stock, par value $0.001 per share
2021-07-15+115,759→ 1,595,209 total(indirect: Shares held through RGD Investissements S.A.S. and Lombard International Assurance SA) - Exercise/Conversion
Common Stock, par value $0.001 per share
2021-07-15+5,000→ 1,600,209 total(indirect: Shares held through RGD Investissements S.A.S. and Lombard International Assurance SA)
Holdings
- 61,256
Common Stock, par value $0.001 per share
Footnotes (2)
- [F1]Payment of exercise price was satisfied through the satisfaction of an Issuer promissory note held by the Reporting Person.
- [F2]The options vested 1,666 on May 31, 2019, 1,666 on November 30, 2019 and 1,668 on May 31, 2020.
Documents
Issuer
Bionik Laboratories Corp.
CIK 0001508381
Entity typeother
Related Parties
1- filerCIK 0001716639
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:32 PM ET
- Size
- 11.9 KB